Regentis Biomaterials expanded its clinical trial of GelrinC for the treatment of articular knee cartilage damage to 11 U.S. sites.
The Latest
Life Spine experienced a 124 percent earnings before interest, tax, depreciation and amortization growth rate in the third quarter of 2018 compared to the same period in 2017.
Medtronic received FDA approval for its SynchroMed II myPTM Personal Therapy Manager for chronic pain patients.
As physician payment models become increasingly complex, physician practices have become more risk-averse, according to a study by the Rand Corporation and the American Medical Association.
Priscilla Pang, MD, joined Bend, Ore.-based The Center Orthopedic & Neurosurgical Care & Research.
Beaver Dam (Wis.) Community Hospital launched its Institute for Movement and Orthopedics, according to Daily Citizen.
Here are 20 key notes from orthopedic and spine device companies in the past week.
Tampa, Fla.-based Physician Partners of America welcomed Anthony Clavo, MD, to its Arlington, Texas, location.
A study in The Spine Journal examined if a standardized patient selection protocol for outpatient anterior cervical discectomy and fusion resulted in noninferior readmission rates compared to overnight admissions.
After filing updated financial figures with the Security and Exchange Commission, K2M settled its ongoing litigation with Stryker.